assessing the efficacy of antibodies targeting α-synuclein
Published 1 year ago • 108 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
3:01
the value of alpha-synuclein as a putative target for therapeutic intervention in synucleinopathies
-
1:54
targeting α-synuclein as a therapy for parkinson’s disease: strategies in the pipeline
-
2:05
alpha-synuclein inhibitors, kinase inhibitors & targeting mitochondria in parkinson’s disease
-
1:26
targeting α-synuclein & neuroinflammation in parkinson's disease
-
1:29
prasinezumab: an anti-alpha-synuclein antibody in parkinson's disease
-
4:31
is α-synuclein a useful therapeutic target in parkinson's disease?
-
1:21
investigating α-synuclein aggregation as a therapeutic target in parkinson’s disease
-
2:26
alpha-synuclein as a therapeutic target for parkinson's disease
-
5:03
a novel method for detection of early oligomeric α-synuclein pathology
-
4:00
peripheral α-synuclein as a parkinson’s disease biomarker
-
2:03
what is the future of immunotherapy in parkinson’s disease?
-
1:46
therapeutic approaches to target alpha-synuclein in parkinson’s disease
-
2:02
glycation of α-synuclein in parkinson’s disease
-
1:45
the current and future scope of α-synuclein research
-
21:23
parkinson’s disease: current status and potential role of emerging agents targeting alpha-synuclein
-
1:42
investigating the relevance of alpha-synuclein localization in synucleinopathies
-
1:21
alpha-synuclein pet tracers to detect parkinson’s disease
-
1:06
peripheral neuropathy and parkinson’s: α-synuclein aggregation
-
1:52
epigenomic and epitranscriptomic effects of α-synuclein in the nucleus